Liver Fibrosis Clinical Trials in Beijing
3 recruitingBeijing, China
Showing 1–3 of 3 trials
Recruiting
Phase 3
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
Metabolic dysfunction-associated steatohepatitis (MASH)Liver Fibrosis
Boehringer Ingelheim1,800 enrolled526 locationsNCT06632444
Recruiting
Phase 3
Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
Liver Fibrosis
Beijing Continent Pharmaceutical Co, Ltd.248 enrolled23 locationsNCT05905172
Recruiting
Non-Invasive Model for Fibrosis Regression in HBV Patients
Chronic Hepatitis B Virus (HBV) InfectionLiver Fibrosis
Beijing Friendship Hospital1,100 enrolled1 locationNCT06874127